Cargando…
RET Gene Abnormalities and Thyroid Disease: Who Should be Screened and When
Mutations in the RET proto-oncogene have been implicated in the pathogenesis of several forms of medullary thyroid cancer (MTC). Multiple endocrine neoplasia type 2 (MEN-2) is an autosomal dominant syndrome caused by germline activating mutations of the RET proto-oncogene and has been categorized in...
Autores principales: | Salehian, Behrouz, Samoa, Raynald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608003/ https://www.ncbi.nlm.nih.gov/pubmed/23455356 http://dx.doi.org/10.4274/Jcrpe.870 |
Ejemplares similares
-
RET kinase inhibitors for RET-altered thyroid cancers
por: Vodopivec, Danica M., et al.
Publicado: (2022) -
Pediatric Thyroid Disease: When is Surgery Necessary, and Who Should be Operating on Our Children?
por: Breuer, Christopher, et al.
Publicado: (2013) -
RET Gene Fusions in Malignancies of the Thyroid and Other Tissues
por: Santoro, Massimo, et al.
Publicado: (2020) -
The Role of Helicobacter pylori Seropositivity in Insulin Sensitivity, Beta Cell Function, and Abnormal Glucose Tolerance
por: Malamug, Lou Rose, et al.
Publicado: (2014) -
Post-Traumatic Hypopituitarism—Who Should Be Screened, When, and How?
por: Quinn, Mark, et al.
Publicado: (2018)